244 related articles for article (PubMed ID: 34433568)
1. Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals.
Parker JL; Deme JC; Wu Z; Kuteyi G; Huo J; Owens RJ; Biggin PC; Lea SM; Newstead S
Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34433568
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in understanding prodrug transport through the SLC15 family of proton-coupled transporters.
Minhas GS; Newstead S
Biochem Soc Trans; 2020 Apr; 48(2):337-346. PubMed ID: 32219385
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for prodrug recognition by the SLC15 family of proton-coupled peptide transporters.
Minhas GS; Newstead S
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):804-809. PubMed ID: 30602453
[TBL] [Abstract][Full Text] [Related]
4. Extracellular domain of PepT1 interacts with TM1 to facilitate substrate transport.
Shen J; Hu M; Fan X; Ren Z; Portioli C; Yan X; Rong M; Zhou M
Structure; 2022 Jul; 30(7):1035-1041.e3. PubMed ID: 35580608
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for antibiotic transport and inhibition in PepT2, the mammalian proton-coupled peptide transporter.
Newstead S; Parker J; Deme J; Lichtinger S; Kuteyi G; Biggin P; Lea S
Res Sq; 2024 May; ():. PubMed ID: 38903084
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in understanding proton coupled peptide transport via the POT family.
Newstead S
Curr Opin Struct Biol; 2017 Aug; 45():17-24. PubMed ID: 27865112
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into proton coupled peptide transport in the PTR family of oligopeptide transporters.
Newstead S
Biochim Biophys Acta; 2015 Mar; 1850(3):488-99. PubMed ID: 24859687
[TBL] [Abstract][Full Text] [Related]
8. Crystal Structures of the Extracellular Domain from PepT1 and PepT2 Provide Novel Insights into Mammalian Peptide Transport.
Beale JH; Parker JL; Samsudin F; Barrett AL; Senan A; Bird LE; Scott D; Owens RJ; Sansom MSP; Tucker SJ; Meredith D; Fowler PW; Newstead S
Structure; 2015 Oct; 23(10):1889-1899. PubMed ID: 26320580
[TBL] [Abstract][Full Text] [Related]
9. Biology of Peptide Transporter 2 in Mammals: New Insights into Its Function, Structure and Regulation.
Wang C; Chu C; Ji X; Luo G; Xu C; He H; Yao J; Wu J; Hu J; Jin Y
Cells; 2022 Sep; 11(18):. PubMed ID: 36139448
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.
Newstead S; Drew D; Cameron AD; Postis VL; Xia X; Fowler PW; Ingram JC; Carpenter EP; Sansom MS; McPherson MJ; Baldwin SA; Iwata S
EMBO J; 2011 Jan; 30(2):417-26. PubMed ID: 21131908
[TBL] [Abstract][Full Text] [Related]
11. Expression of the peptide transporters PepT1, PepT2, and PHT1 in the embryonic and posthatch chick.
Zwarycz B; Wong EA
Poult Sci; 2013 May; 92(5):1314-21. PubMed ID: 23571341
[TBL] [Abstract][Full Text] [Related]
12. Structure of Prototypic Peptide Transporter DtpA from E. coli in Complex with Valganciclovir Provides Insights into Drug Binding of Human PepT1.
Ural-Blimke Y; Flayhan A; Strauss J; Rantos V; Bartels K; Nielsen R; Pardon E; Steyaert J; Kosinski J; Quistgaard EM; Löw C
J Am Chem Soc; 2019 Feb; 141(6):2404-2412. PubMed ID: 30644743
[TBL] [Abstract][Full Text] [Related]
13. Peptide transporters: structure, function, regulation and application for drug delivery.
Terada T; Inui K
Curr Drug Metab; 2004 Feb; 5(1):85-94. PubMed ID: 14965252
[TBL] [Abstract][Full Text] [Related]
14. Peptide transporter structure reveals binding and action mechanism of a potent PEPT1 and PEPT2 inhibitor.
Stauffer M; Jeckelmann JM; Ilgü H; Ucurum Z; Boggavarapu R; Fotiadis D
Commun Chem; 2022 Feb; 5(1):23. PubMed ID: 36697632
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2.
Fujita T; Kishida T; Wada M; Okada N; Yamamoto A; Leibach FH; Ganapathy V
Brain Res; 2004 Jan; 997(1):52-61. PubMed ID: 14715149
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.
Terada T; Sawada K; Irie M; Saito H; Hashimoto Y; Inui K
Pflugers Arch; 2000 Sep; 440(5):679-84. PubMed ID: 11007306
[TBL] [Abstract][Full Text] [Related]
17. Proton-Coupled Oligopeptide Transport (Slc15) in the Brain: Past and Future Research.
Xiang J; Keep RF
Pharm Res; 2023 Nov; 40(11):2533-2540. PubMed ID: 37308743
[TBL] [Abstract][Full Text] [Related]
18. Proton movement and coupling in the POT family of peptide transporters.
Parker JL; Li C; Brinth A; Wang Z; Vogeley L; Solcan N; Ledderboge-Vucinic G; Swanson JMJ; Caffrey M; Voth GA; Newstead S
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13182-13187. PubMed ID: 29180426
[TBL] [Abstract][Full Text] [Related]
19. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.
Sugawara M; Huang W; Fei YJ; Leibach FH; Ganapathy V; Ganapathy ME
J Pharm Sci; 2000 Jun; 89(6):781-9. PubMed ID: 10824137
[TBL] [Abstract][Full Text] [Related]
20. Alternate expression of PEPT1 and PEPT2 in epidermal differentiation is required for NOD2 immune responses by bacteria-derived muramyl dipeptide.
Kudo M; Kobayashi-Nakamura K; Kitajima N; Tsuji-Naito K
Biochem Biophys Res Commun; 2020 Jan; 522(1):151-156. PubMed ID: 31757425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
